This content is in French.
PSMA, a revolution against prostate cancer
4 février 2025
#ProstateCancer #Cancer #Prostate #Therapy #Innovation #PSMATargetedTherapy #Immunotherapy
Prostate cancer is one of the most common cancers in men and remains a leading cause of cancer-related mortality worldwide. With increasing life expectancy and improved screening techniques, its incidence continues to rise. While conventional treatments—hormone therapy, chemotherapy, and radiotherapy—can control the disease in its early stages, their effectiveness significantly declines as the cancer progresses into more aggressive forms.
Prostate cancer is one of the most common cancers in men and remains a leading cause of cancer-related mortality worldwide. With increasing life expectancy and improved screening techniques, its incidence continues to rise. While conventional treatments—hormone therapy, chemotherapy, and radiotherapy—can control the disease in its early stages, their effectiveness significantly declines as the cancer progresses into more aggressive forms.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Mattana, F., et al. (2024). Prostate-Specific Membrane Antigen-Targeted Therapy in Prostate Cancer: History, Combination Therapies, Trials, and Future Perspective. Cancers, 16(9), 1643
View the source
